Infusion added to Keppra range

UCB Pharma has added Keppra intravenous infusion containing levetiracetam 100mg per ml to its range of antiepileptic products.

Keppra infusion is supplied as a concentrate that must be diluted in at least 100ml of a compatible diluent before being administered as an intravenous infusion over 15 minutes.

Keppra infusion provides an alternative for patients when oral administration is temporarily not feasible. Conversion to and from oral administration can be done directly without titration, but the total daily dose and frequency of administration should be maintained. There is no experience with administration of the infusion for periods longer than four days.

Keppra infusion 100mg per ml is supplied in 5ml vials in packs of 10 at a cost of £135.00.

Further information: UCB Pharma Ltd, 208 Bath Road, Slough, Berkshire SL1 3WE. Tel: (01753) 534655.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases